Active 0 6 0 6 O
vaginal 7 14 7 14 B-clinical_variable
bleeding 15 23 15 23 I-clinical_variable
greater 24 31 24 31 O
than 32 36 32 36 O
spotting 37 45 37 45 O
at 46 48 46 48 O
the 49 52 49 52 O
time 53 57 53 57 O
of 58 60 58 60 O
randomization 61 74 61 74 O
, 74 75 74 75 O
because 76 83 76 83 O
of 84 86 84 86 O
potential 87 96 87 96 O
exacerbation 97 109 97 109 O
due 110 113 110 113 O
to 114 116 114 116 O
pessary 117 124 117 124 B-treatment
placement 125 134 125 134 I-treatment

Active 0 6 135 141 O
, 6 7 141 142 O
unhealed 8 16 143 151 O
herpetic 17 25 152 160 B-chronic_disease
lesion 26 32 161 167 I-chronic_disease
on 33 35 168 170 I-chronic_disease
labia 36 41 171 176 I-chronic_disease
minora 42 48 177 183 I-chronic_disease
, 48 49 183 184 O
vagina 50 56 185 191 B-chronic_disease
, 56 57 191 192 O
or 58 60 193 195 O
cervix 61 67 196 202 B-chronic_disease
due 68 71 203 206 O
to 72 74 207 209 O
the 75 78 210 213 O
potential 79 88 214 223 O
for 89 92 224 227 O
significant 93 104 228 239 O
patient 105 112 240 247 O
discomfort 113 123 248 258 O
or 124 126 259 261 O
increasing 127 137 262 272 O
genital 138 145 273 280 O
tract 146 151 281 286 O
viral 152 157 287 292 O
spread 158 164 293 299 O
. 164 165 299 300 O
Once 166 170 301 305 O
lesion(s 171 179 306 314 O
) 179 180 314 315 O
heal 181 185 316 320 O
and 186 189 321 324 O
the 190 193 325 328 O
patient 194 201 329 336 O
is 202 204 337 339 O
asymptomatic 205 217 340 352 O
, 217 218 352 353 O
she 219 222 354 357 O
may 223 226 358 361 O
be 227 229 362 364 O
randomized 230 240 365 375 O

Allergy 0 7 376 383 O
to 8 10 384 386 O
progesterone 11 23 387 399 B-allergy_name
, 23 24 399 400 O
silicone 25 33 401 409 B-allergy_name
, 33 34 409 410 O
or 35 37 411 413 O
excipients 38 48 414 424 O
in 49 51 425 427 O
the 52 55 428 431 O
study 56 61 432 437 B-treatment
drug 62 66 438 442 I-treatment
, 66 67 442 443 O
including 68 77 444 453 O
peanuts 78 85 454 461 B-allergy_name
or 86 88 462 464 O
peanut 89 95 465 471 B-allergy_name
oil 96 99 472 475 I-allergy_name
in 100 102 476 478 O
the 103 106 479 482 O
study 107 112 483 488 O
drug 113 117 489 493 O
or 118 120 494 496 O
placebo 121 128 497 504 B-allergy_name

Any 0 3 505 508 O
fetal 4 9 509 514 B-chronic_disease
/ 9 10 514 515 O
maternal 10 18 515 523 B-chronic_disease
condition 19 28 524 533 I-chronic_disease
which 29 34 534 539 O
would 35 40 540 545 O
require 41 48 546 553 O
invasive 49 57 554 562 O
in 58 60 563 565 O
- 60 61 565 566 O
utero 61 66 566 571 O
assessment 67 77 572 582 O
or 78 80 583 585 O
treatment 81 90 586 595 B-treatment
, 90 91 595 596 O
for 92 95 597 600 O
example 96 103 601 608 O
significant 104 115 609 620 O
red 116 119 621 624 O
cell 120 124 625 629 O
antigen 125 132 630 637 O
sensitization 133 146 638 651 O
or 147 149 652 654 O
neonatal 150 158 655 663 B-chronic_disease
alloimmune 159 169 664 674 I-chronic_disease
thrombocytopenia 170 186 675 691 I-chronic_disease

Cervical 0 8 692 700 O
dilation 9 17 701 709 O
( 18 19 710 711 O
internal 19 27 711 719 O
os 28 30 720 722 O
) 30 31 722 723 O
3 32 33 724 725 B-lower_bound
cm 34 36 726 728 I-lower_bound
or 37 39 729 731 O
greater 40 47 732 739 O
on 48 50 740 742 O
digital 51 58 743 750 B-treatment
examination 59 70 751 762 I-treatment
or 71 73 763 765 O
evidence 74 82 766 774 O
of 83 85 775 777 O
prolapsed 86 95 778 787 O
membranes 96 105 788 797 O
beyond 106 112 798 804 O
the 113 116 805 808 O
external 117 125 809 817 O
cervical 126 134 818 826 O
os 135 137 827 829 O
either 138 144 830 836 O
at 145 147 837 839 O
the 148 151 840 843 O
time 152 156 844 848 O
of 157 159 849 851 O
the 160 163 852 855 O
qualifying 164 174 856 866 O
cervical 175 183 867 875 B-treatment
ultrasound 184 194 876 886 I-treatment
examination 195 206 887 898 I-treatment
or 207 209 899 901 O
at 210 212 902 904 O
a 213 214 905 906 O
cervical 215 223 907 915 O
exam 224 228 916 920 O
immediately 229 240 921 932 O
before 241 247 933 939 O
randomization 248 261 940 953 O
. 261 262 953 954 O
There 263 268 955 960 O
is 269 271 961 963 O
no 272 274 964 966 O
lower 275 280 967 972 O
threshold 281 290 973 982 O
of 291 293 983 985 O
cervical 294 302 986 994 O
length 303 309 995 1001 O
measurement 310 321 1002 1013 O
threshold 322 331 1014 1023 O
on 332 334 1024 1026 O
ultrasound 335 345 1027 1037 O

Cervical 0 8 1038 1046 O
length 9 15 1047 1053 O
on 16 18 1054 1056 O
transvaginal 19 31 1057 1069 B-treatment
examination 32 43 1070 1081 I-treatment
of 44 46 1082 1084 O
less 47 51 1085 1089 O
than 52 56 1090 1094 O
30 57 59 1095 1097 B-upper_bound
mm 60 62 1098 1100 I-upper_bound
within 63 69 1101 1107 O
10 70 72 1108 1110 B-upper_bound
days 73 77 1111 1115 I-upper_bound
prior 78 83 1116 1121 I-upper_bound
to 84 86 1122 1124 O
randomization 87 100 1125 1138 O
by 101 103 1139 1141 O
a 104 105 1142 1143 O
study 106 111 1144 1149 O
certified 112 121 1150 1159 O
sonographer 122 133 1160 1171 O

Evidence 0 8 1172 1180 O
of 9 11 1181 1183 O
severe 12 18 1184 1190 B-chronic_disease
IUGR 19 23 1191 1195 I-chronic_disease
( 24 25 1196 1197 I-chronic_disease
intrauterine 25 37 1197 1209 I-chronic_disease
growth 38 44 1210 1216 I-chronic_disease
restriction 45 56 1217 1228 I-chronic_disease
) 56 57 1228 1229 I-chronic_disease
( 58 59 1230 1231 O
< 59 60 1231 1232 O
5th 60 63 1232 1235 B-upper_bound
percentile 64 74 1236 1246 I-upper_bound
for 75 78 1247 1250 O
gestational 79 90 1251 1262 B-clinical_variable
age 91 94 1263 1266 I-clinical_variable
) 94 95 1266 1267 O
in 96 98 1268 1270 O
either 99 105 1271 1277 O
fetus 106 111 1278 1283 O

Fetal 0 5 1284 1289 B-chronic_disease
anomaly 6 13 1290 1297 I-chronic_disease
in 14 16 1298 1300 O
either 17 23 1301 1307 O
twin 24 28 1308 1312 O
or 29 31 1313 1315 O
imminent 32 40 1316 1324 O
fetal 41 46 1325 1330 O
demise 47 53 1331 1337 O
. 53 54 1337 1338 O
This 55 59 1339 1343 O
includes 60 68 1344 1352 O
lethal 69 75 1353 1359 B-chronic_disease
anomalies 76 85 1360 1369 I-chronic_disease
, 85 86 1369 1370 O
or 87 89 1371 1373 O
anomalies 90 99 1374 1383 O
that 100 104 1384 1388 O
may 105 108 1389 1392 O
lead 109 113 1393 1397 O
to 114 116 1398 1400 O
early 117 122 1401 1406 O
delivery 123 131 1407 1415 O
or 132 134 1416 1418 O
increased 135 144 1419 1428 O
risk 145 149 1429 1433 O
of 150 152 1434 1436 O
neonatal 153 161 1437 1445 O
death 162 167 1446 1451 O
e.g. 168 172 1452 1456 O
, 172 173 1456 1457 O
gastroschisis 174 187 1458 1471 B-chronic_disease
, 187 188 1471 1472 O
spina 189 194 1473 1478 B-chronic_disease
bifida 195 201 1479 1485 I-chronic_disease
, 201 202 1485 1486 O
serious 203 210 1487 1494 O
karyotypic 211 221 1495 1505 B-chronic_disease
abnormalities 222 235 1506 1519 I-chronic_disease
) 235 236 1519 1520 O
. 236 237 1520 1521 O
An 238 240 1522 1524 O
ultrasound 241 251 1525 1535 O
examination 252 263 1536 1547 O
from 264 268 1548 1552 O
14 269 271 1553 1555 B-lower_bound
weeks 272 277 1556 1561 I-lower_bound
0 278 279 1562 1563 I-lower_bound
days 280 284 1564 1568 I-lower_bound
to 285 287 1569 1571 O
23 288 290 1572 1574 B-upper_bound
weeks 291 296 1575 1580 I-upper_bound
6 297 298 1581 1582 I-upper_bound
days 299 303 1583 1587 I-upper_bound
by 304 306 1588 1590 O
project 307 314 1591 1598 O
EDC 315 318 1599 1602 O
( 319 320 1603 1604 O
estimated 320 329 1604 1613 O
date 330 334 1614 1618 O
of 335 337 1619 1621 O
conception 338 348 1622 1632 O
) 348 349 1632 1633 O
must 350 354 1634 1638 O
be 355 357 1639 1641 O
performed 358 367 1642 1651 O
prior 368 373 1652 1657 O
to 374 376 1658 1660 O
randomization 377 390 1661 1674 O
to 391 393 1675 1677 O
evaluate 394 402 1678 1686 O
the 403 406 1687 1690 O
fetuses 407 414 1691 1698 O
for 415 418 1699 1702 O
anomalies 419 428 1703 1712 O

Gestational 0 11 1713 1724 B-clinical_variable
age 12 15 1725 1728 I-clinical_variable
at 16 18 1729 1731 O
randomization 19 32 1732 1745 O
between 33 40 1746 1753 O
16 41 43 1754 1756 B-lower_bound
weeks 44 49 1757 1762 I-lower_bound
0 50 51 1763 1764 I-lower_bound
days 52 56 1765 1769 I-lower_bound
and 57 60 1770 1773 O
23 61 63 1774 1776 B-upper_bound
weeks 64 69 1777 1782 I-upper_bound
6 70 71 1783 1784 I-upper_bound
days 72 76 1785 1789 I-upper_bound
based 77 82 1790 1795 O
on 83 85 1796 1798 O
clinical 86 94 1799 1807 O
information 95 106 1808 1819 O
and 107 110 1820 1823 O
evaluation 111 121 1824 1834 O
of 122 124 1835 1837 O
the 125 128 1838 1841 O
earliest 129 137 1842 1850 O
ultrasound 138 148 1851 1861 O

History 0 7 1862 1869 O
of 8 10 1870 1872 O
herpes 11 17 1873 1879 B-chronic_disease

Known 0 5 1880 1885 O
liver 6 11 1886 1891 B-chronic_disease
dysfunction 12 23 1892 1903 I-chronic_disease
or 24 26 1904 1906 O
disease 27 34 1907 1914 O
because 35 42 1915 1922 O
liver 43 48 1923 1928 B-chronic_disease
disease 49 56 1929 1936 I-chronic_disease
is 57 59 1937 1939 O
a 60 61 1940 1941 O
contraindication 62 78 1942 1958 O
to 79 81 1959 1961 O
the 82 85 1962 1965 O
active 86 92 1966 1972 O
study 93 98 1973 1978 B-treatment
medication 99 109 1979 1989 I-treatment

Known 0 5 1990 1995 O
major 6 11 1996 2001 O
Mullerian 12 21 2002 2011 B-chronic_disease
anomaly 22 29 2012 2019 I-chronic_disease
of 30 32 2020 2022 I-chronic_disease
the 33 36 2023 2026 I-chronic_disease
uterus 37 43 2027 2033 I-chronic_disease
( 44 45 2034 2035 O
specifically 45 57 2035 2047 O
bicornuate 58 68 2048 2058 B-chronic_disease
, 68 69 2058 2059 O
unicornuate 70 81 2060 2071 B-chronic_disease
, 81 82 2071 2072 O
or 83 85 2073 2075 O
uterine 86 93 2076 2083 B-chronic_disease
septum 94 100 2084 2090 I-chronic_disease
not 101 104 2091 2094 O
resected 105 113 2095 2103 O
) 113 114 2103 2104 O
due 115 118 2105 2108 O
to 119 121 2109 2111 O
increased 122 131 2112 2121 O
risk 132 136 2122 2126 O
of 137 139 2127 2129 O
preterm 140 147 2130 2137 O
delivery 148 156 2138 2146 O
which 157 162 2147 2152 O
is 163 165 2153 2155 O
unlikely 166 174 2156 2164 O
to 175 177 2165 2167 O
be 178 180 2168 2170 O
affected 181 189 2171 2179 O
by 190 192 2180 2182 O
progesterone 193 205 2183 2195 B-treatment

Known 0 5 2196 2201 O
, 5 6 2201 2202 O
suspected 7 16 2203 2212 O
or 17 19 2213 2215 O
history 20 27 2216 2223 O
of 28 30 2224 2226 O
breast 31 37 2227 2233 B-cancer
cancer 38 44 2234 2240 I-cancer
because 45 52 2241 2248 O
breast 53 59 2249 2255 O
cancer 60 66 2256 2262 O
is 67 69 2263 2265 O
a 70 71 2266 2267 O
contraindication 72 88 2268 2284 O
to 89 91 2285 2287 O
the 92 95 2288 2291 O
active 96 102 2292 2298 O
study 103 108 2299 2304 O
medication 109 119 2305 2315 B-treatment

Major 0 5 2316 2321 O
maternal 6 14 2322 2330 O
medical 15 22 2331 2338 O
illness 23 30 2339 2346 O
associated 31 41 2347 2357 O
with 42 46 2358 2362 O
increased 47 56 2363 2372 O
risk 57 61 2373 2377 O
for 62 65 2378 2381 O
adverse 66 73 2382 2389 O
pregnancy 74 83 2390 2399 B-pregnancy
outcome 84 91 2400 2407 O
or 92 94 2408 2410 O
indicated 95 104 2411 2420 O
preterm 105 112 2421 2428 O
birth 113 118 2429 2434 O
( 119 120 2435 2436 O
treated 120 127 2436 2443 O
hypertension 128 140 2444 2456 B-chronic_disease
requiring 141 150 2457 2466 O
more 151 155 2467 2471 O
than 156 160 2472 2476 O
one 161 164 2477 2480 B-lower_bound
agent 165 170 2481 2486 O
, 170 171 2486 2487 O
pre 172 175 2488 2491 B-treatment
- 175 176 2491 2492 I-treatment
gestational 176 187 2492 2503 I-treatment
treatment 188 197 2504 2513 I-treatment
for 198 201 2514 2517 O
diabetes 202 210 2518 2526 B-chronic_disease
prior 211 216 2527 2532 O
to 217 219 2533 2535 O
pregnancy 220 229 2536 2545 O
, 229 230 2545 2546 O
chronic 231 238 2547 2554 O
renal 239 244 2555 2560 B-chronic_disease
insufficiency 245 258 2561 2574 I-chronic_disease
failure 259 266 2575 2582 O
defined 267 274 2583 2590 O
by 275 277 2591 2593 O
creatinine 278 288 2594 2604 B-clinical_variable
> 289 290 2605 2606 O
1.4 290 293 2606 2609 B-lower_bound
mg 294 296 2610 2612 I-lower_bound
/ 296 297 2612 2613 I-lower_bound
dL 297 299 2613 2615 I-lower_bound
, 299 300 2615 2616 O
carcinoma 301 310 2617 2626 B-cancer
of 311 313 2627 2629 I-cancer
the 314 317 2630 2633 I-cancer
breast 318 324 2634 2640 I-cancer
, 324 325 2640 2641 O
conditions 326 336 2642 2652 O
treated 337 344 2653 2660 O
with 345 349 2661 2665 O
chronic 350 357 2666 2673 B-treatment
oral 358 362 2674 2678 I-treatment
glucocorticoid 363 377 2679 2693 I-treatment
therapy 378 385 2694 2701 I-treatment

Monoamniotic 0 12 2702 2714 O
gestation 13 22 2715 2724 O
, 22 23 2724 2725 O
due 24 27 2726 2729 O
to 28 30 2730 2732 O
increased 31 40 2733 2742 O
risk 41 45 2743 2747 O
of 46 48 2748 2750 O
adverse 49 56 2751 2758 O
pregnancy 57 66 2759 2768 B-pregnancy
outcome 67 74 2769 2776 O

More 0 4 2777 2781 O
than 5 9 2782 2786 O
six 10 13 2787 2790 B-lower_bound
contractions 14 26 2791 2803 O
per 27 30 2804 2807 O
hour 31 35 2808 2812 O
reported 36 44 2813 2821 O
or 45 47 2822 2824 O
documented 48 58 2825 2835 O
prior 59 64 2836 2841 O
to 65 67 2842 2844 O
randomization 68 81 2845 2858 O
. 81 82 2858 2859 O
It 83 85 2860 2862 O
is 86 88 2863 2865 O
not 89 92 2866 2869 O
necessary 93 102 2870 2879 O
to 103 105 2880 2882 O
place 106 111 2883 2888 O
the 112 115 2889 2892 O
patient 116 123 2893 2900 O
on 124 126 2901 2903 O
a 127 128 2904 2905 O
tocodynamometer 129 144 2906 2921 B-treatment

Participation 0 13 2922 2935 O
in 14 16 2936 2938 O
another 17 24 2939 2946 B-treatment
interventional 25 39 2947 2961 I-treatment
study 40 45 2962 2967 I-treatment
that 46 50 2968 2972 O
influences 51 61 2973 2983 O
gestational 62 73 2984 2995 B-clinical_variable
age 74 77 2996 2999 I-clinical_variable
at 78 80 3000 3002 O
delivery 81 89 3003 3011 O
or 90 92 3012 3014 O
neonatal 93 101 3015 3023 O
morbidity 102 111 3024 3033 O
or 112 114 3034 3036 O
mortality 115 124 3037 3046 O

Participation 0 13 3047 3060 O
in 14 16 3061 3063 O
this 17 21 3064 3068 O
trial 22 27 3069 3074 O
in 28 30 3075 3077 O
a 31 32 3078 3079 O
previous 33 41 3080 3088 O
pregnancy 42 51 3089 3098 B-pregnancy

Patients 0 8 3099 3107 O
who 9 12 3108 3111 O
were 13 17 3112 3116 O
screened 18 26 3117 3125 O
in 27 29 3126 3128 O
a 30 31 3129 3130 O
previous 32 40 3131 3139 O
pregnancy 41 50 3140 3149 B-pregnancy
, 50 51 3149 3150 O
but 52 55 3151 3154 O
not 56 59 3155 3158 O
randomized 60 70 3159 3169 O

Placenta 0 8 3170 3178 B-chronic_disease
previa 9 15 3179 3185 I-chronic_disease
, 15 16 3185 3186 O
because 17 24 3187 3194 O
of 25 27 3195 3197 O
risk 28 32 3198 3202 O
of 33 35 3203 3205 O
bleeding 36 44 3206 3214 O
and 45 48 3215 3218 O
high 49 53 3219 3223 O
potential 54 63 3224 3233 O
for 64 67 3234 3237 O
indicated 68 77 3238 3247 O
preterm 78 85 3248 3255 O
birth 86 91 3256 3261 O

Planned 0 7 3262 3269 O
cerclage 8 16 3270 3278 B-treatment
or 17 19 3279 3281 O
cerclage 20 28 3282 3290 O
already 29 36 3291 3298 O
in 37 39 3299 3301 O
place 40 45 3302 3307 O
since 46 51 3308 3313 O
it 52 54 3314 3316 O
would 55 60 3317 3322 O
preclude 61 69 3323 3331 O
placement 70 79 3332 3341 O
of 80 82 3342 3344 O
a 83 84 3345 3346 O
pessary 85 92 3347 3354 B-treatment

Planned 0 7 3355 3362 O
or 8 10 3363 3365 O
actual 11 17 3366 3372 O
progesterone 18 30 3373 3385 B-treatment
treatment 31 40 3386 3395 I-treatment
of 41 43 3396 3398 O
any 44 47 3399 3402 O
type 48 52 3403 3407 O
or 53 55 3408 3410 O
form 56 60 3411 3415 O
after 61 66 3416 3421 B-upper_bound
14 67 69 3422 3424 I-upper_bound
weeks 70 75 3425 3430 I-upper_bound
6 76 77 3431 3432 I-upper_bound
days 78 82 3433 3437 I-upper_bound
during 83 89 3438 3444 O
the 90 93 3445 3448 O
current 94 101 3449 3456 B-pregnancy
pregnancy 102 111 3457 3466 I-pregnancy

Rupture 0 7 3467 3474 O
of 8 10 3475 3477 O
membranes 11 20 3478 3487 O
due 21 24 3488 3491 O
to 25 27 3492 3494 O
likelihood 28 38 3495 3505 O
of 39 41 3506 3508 O
pregnancy 42 51 3509 3518 B-pregnancy
loss 52 56 3519 3523 O
and 57 60 3524 3527 O
preterm 61 68 3528 3535 O
delivery 69 77 3536 3544 O
as 78 80 3545 3547 O
well 81 85 3548 3552 O
as 86 88 3553 3555 O
the 89 92 3556 3559 O
risk 93 97 3560 3564 O
of 98 100 3565 3567 O
ascending 101 110 3568 3577 O
infection 111 120 3578 3587 B-chronic_disease
which 121 126 3588 3593 O
could 127 132 3594 3599 O
be 133 135 3600 3602 O
increased 136 145 3603 3612 O
with 146 150 3613 3617 O
pessary 151 158 3618 3625 O
placement 159 168 3626 3635 O

Specifically 0 12 3636 3648 O
, 12 13 3648 3649 O
patients 14 22 3650 3658 O
with 23 27 3659 3663 O
seizure 28 35 3664 3671 B-chronic_disease
disorders 36 45 3672 3681 I-chronic_disease
, 45 46 3681 3682 O
HIV 47 50 3683 3686 B-chronic_disease
, 50 51 3686 3687 O
and 52 55 3688 3691 O
other 56 61 3692 3697 O
medical 62 69 3698 3705 O
conditions 70 80 3706 3716 O
not 81 84 3717 3720 O
specifically 85 97 3721 3733 O
associated 98 108 3734 3744 O
with 109 113 3745 3749 O
an 114 116 3750 3752 O
increased 117 126 3753 3762 O
risk 127 131 3763 3767 O
of 132 134 3768 3770 O
indicated 135 144 3771 3780 O
preterm 145 152 3781 3788 O
birth 153 158 3789 3794 O
are 159 162 3795 3798 O
not 163 166 3799 3802 O
excluded 167 175 3803 3811 O
. 175 176 3811 3812 O
Prior 177 182 3813 3818 B-treatment
cervical 183 191 3819 3827 I-treatment
cone 192 196 3828 3832 I-treatment
/ 196 197 3832 3833 O
LOOP 197 201 3833 3837 B-treatment
/ 201 202 3837 3838 O
LEEP 202 206 3838 3842 B-treatment

Twin 0 4 3843 3847 B-chronic_disease
- 4 5 3847 3848 I-chronic_disease
twin 5 9 3848 3852 I-chronic_disease
transfusion 10 21 3853 3864 I-chronic_disease
syndrome 22 30 3865 3873 I-chronic_disease
, 30 31 3873 3874 O
due 32 35 3875 3878 O
to 36 38 3879 3881 O
increased 39 48 3882 3891 O
risk 49 53 3892 3896 O
of 54 56 3897 3899 O
adverse 57 64 3900 3907 O
pregnancy 65 74 3908 3917 B-pregnancy
outcome 75 82 3918 3925 O

